It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
While the precise processes underlying a sex bias in the development of central nervous system (CNS) disorders are unknown, there is growing evidence that an early life immune activation can contribute to the disease pathogenesis. When we mimicked an early systemic viral infection or applied murine cytomegalovirus (MCMV) systemically in neonatal female and male mice, only male adolescent mice presented behavioral deficits, including reduced social behavior and cognition. This was paralleled by an increased amount of infiltrating T cells in the brain parenchyma, enhanced interferon-γ (IFNγ) signaling, and epigenetic reprogramming of microglial cells. These microglial cells showed increased phagocytic activity, which resulted in abnormal loss of excitatory synapses within the hippocampal brain region. None of these alterations were seen in female adolescent mice. Our findings underscore the early postnatal period’s susceptibility to cause sex-dependent long-term CNS deficiencies following infections.
Early life inflammation has been linked to neurodevelopmental outcomes. Here the authors show that in mice, neonatal immune challenge results in CD3 + T cell infiltration to brain parenchyma, and microglial activation, to a greater extent in males than females.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Freiburg, Institute of Neuropathology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
2 University of Freiburg, Institute of Neuropathology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Faculty of Biology, Freiburg, Germany (GRID:grid.5963.9)
3 University of Freiburg, Faculty of Medicine, University of Freiburg, Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Freiburg, Germany (GRID:grid.5963.9)
4 University of Freiburg, Department of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for Basics in Neuromodulation (NeuroModulBasics), Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
5 University of Freiburg, Institute for Virology, Faculty of Medicine, Medical Center, Freiburg, Germany (GRID:grid.5963.9)
6 University of Freiburg, Faculty of Medicine, University of Freiburg, Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Faculty of Medicine, University of Freiburg, Center for Pediatrics and Adolescent Medicine, Medical Center, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, CIBSS Centre for Integrative Biological Signalling Studies, Freiburg, Germany (GRID:grid.5963.9)
7 University of Freiburg, Institute of Neuropathology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for Basics in Neuromodulation (NeuroModulBasics), Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Signalling Research Centres BIOSS and CIBSS-Centre for Integrative Biological Signalling Studies, Freiburg, Germany (GRID:grid.5963.9)